2026-10-15T13:24:56Z https://api.figshare.com/v2/oai

oai:figshare.com:article/34512999 2026-10-14T17:26:40Z category_7 category_15 category_21 category_45 category_106 portal_5 item_type_3 month_year_10_2026

<p>Comparison of screening criteria for SLS across four laboratories (Labs A-D) and two commercial providers (Provider A = app-based; Provider B = device-based). Each row lists a screening criterion, with columns indicating whether it was explicitly included in the available protocol. Symbols: ‘✓’ criterion included; ‘—’ not included; ‘○’ qualified or partial inclusion. PSE = photosensitive epilepsy; ‘ ≤ 3y’ = within the last 3 years; FHx = family history; u/wk = units per week; psych. = psychiatric.</p> David John Schwartzman (15208469) Trevor Hewitt (7007630) Timo Torsten Schmidt (5496623) Josemir Wanderley Sander (25823043) Danny Nacker (25823046) James Thurbon (25823049) Vince Polito (4871440) Xaver Funk (24980969) Fiona Macpherson (23277232) Tom Galea (25823052) Gavin Lawson (25823055) Jimi Simpson (25823058) Romy Beauté (23277229) Anil Kumar Seth (25823061) Medicine Neuroscience Biotechnology Sociology Science Policy visually triggered seizure visually provoked seizure serious tolerability concerns proportionate safety guidance principal medical risk immediate stopping procedures beyond laboratory settings 8 million sessions reported operational data establish screening effectiveness specific risk serious events safety practices monitoring procedures laboratory protocols 000 sessions reported seizures reported non reported five systematic adverse synthesis informed syncopal episodes susceptible individual state experiences sensory intolerance retrospective survey predictive performance observational evidence modified participation management approach main concern increasing use focused review figures cannot events across event surveillance event capture estimate incidence commercial adverse <p>Comparison of screening criteria for SLS across four laboratories (Labs A-D) and two commercial providers (Provider A = app-based; Provider B = device-based). Each row lists a screening criterion, with columns indicating whether it was explicitly included in the available protocol. Symbols: ‘✓’ criterion included; ‘—’ not included; ‘○’ qualified or partial inclusion. PSE = photosensitive epilepsy; ‘ ≤ 3y’ = within the last 3 years; FHx = family history; u/wk = units per week; psych. = psychiatric.</p> 2026-10-14T17:26:35Z Dataset Dataset 10.1371/journal.pone.0359958.t001 https://figshare.com/articles/dataset/_p_Comparison_of_screening_criteria_for_SLS_across_four_laboratories_Labs_A-D_and_two_commercial_providers_Provider_A_app-based_Provider_B_device-based_Each_row_lists_a_screening_criterion_with_columns_indicating_whether_it_was_explicitly_i/34512999 CC BY 4.0